Jason Laskey

1.1k total citations
4 papers, 109 citations indexed

About

Jason Laskey is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Jason Laskey has authored 4 papers receiving a total of 109 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 2 papers in Immunology and 1 paper in Molecular Biology. Recurrent topics in Jason Laskey's work include Cancer Immunotherapy and Biomarkers (2 papers), Peptidase Inhibition and Analysis (2 papers) and Hormonal and reproductive studies (1 paper). Jason Laskey is often cited by papers focused on Cancer Immunotherapy and Biomarkers (2 papers), Peptidase Inhibition and Analysis (2 papers) and Hormonal and reproductive studies (1 paper). Jason Laskey collaborates with scholars based in United States. Jason Laskey's co-authors include Joe Jiang Zhu, Weisheng Zhang, Minilik Angagaw, Cyrille Sur, Shailaja Kasibhatla, John F. Reilly, Chris Ware, Pradip K. Majumder, Clay L. Efferson and Jennifer Tammam and has published in prestigious journals such as PLoS ONE, Cancer Research and Oncotarget.

In The Last Decade

Jason Laskey

4 papers receiving 103 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jason Laskey United States	4	79	44	37	20	20	4	109
Cody Weimholt United States	7	91 1.2×	67 1.5×	63 1.7×	32 1.6×	33 1.6×	15	168
Ana Remírez Spain	7	76 1.0×	48 1.1×	37 1.0×	33 1.6×	48 2.4×	9	151
J.J. Soto Castillo Spain	4	50 0.6×	27 0.6×	38 1.0×	12 0.6×	9 0.5×	14	103
Xuemei Zuo United States	5	69 0.9×	53 1.2×	63 1.7×	19 0.9×	24 1.2×	5	136
Marni B. McClure Japan	5	67 0.8×	29 0.7×	41 1.1×	11 0.6×	41 2.0×	7	123
Yeonjoo Hwang United States	3	113 1.4×	23 0.5×	55 1.5×	8 0.4×	29 1.4×	8	148
Desam Roda United Kingdom	5	81 1.0×	29 0.7×	66 1.8×	17 0.8×	44 2.2×	5	152
Paolo Chetta United States	6	71 0.9×	52 1.2×	33 0.9×	17 0.8×	51 2.5×	10	144
Georgia Makrypidi‐Fraune Germany	6	50 0.6×	33 0.8×	52 1.4×	13 0.7×	18 0.9×	7	125
Shi-Bing Li China	3	57 0.7×	29 0.7×	23 0.6×	11 0.6×	51 2.5×	5	107

Countries citing papers authored by Jason Laskey

Since Specialization

Citations

This map shows the geographic impact of Jason Laskey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason Laskey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason Laskey more than expected).

Fields of papers citing papers by Jason Laskey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason Laskey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason Laskey. The network helps show where Jason Laskey may publish in the future.

Co-authorship network of co-authors of Jason Laskey

This figure shows the co-authorship network connecting the top 25 collaborators of Jason Laskey. A scholar is included among the top collaborators of Jason Laskey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason Laskey. Jason Laskey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

4 of 4 papers shown

1.

Wang, Yun, Kelvin Zhang, Peter Georgiev, et al.. (2020). Pharmacological inhibition of hematopoietic progenitor kinase 1 positively regulates T-cell function. PLoS ONE. 15(12). e0243145–e0243145. 29 indexed citations

2.

McLeod, Robbie L., Minilik Angagaw, Toya Nath Baral, et al.. (2018). Characterization of murine CEACAM1 in vivo reveals low expression on CD8+ T cells and no tumor growth modulating activity by anti-CEACAM1 mAb CC1. Oncotarget. 9(77). 34459–34470. 8 indexed citations

3.

Čemerski, Sašo, Shuxia Zhao, Mélissa Chénard, et al.. (2015). T cell activation and anti-tumor efficacy of anti-LAG-3 antibodies is independent of LAG-3 – MHCII blocking capacity. Journal for ImmunoTherapy of Cancer. 3(S2). 6 indexed citations

4.

Zhang, Weisheng, Joe Jiang Zhu, Clay L. Efferson, et al.. (2009). Inhibition of Tumor Growth Progression by Antiandrogens and mTOR Inhibitor in a Pten -Deficient Mouse Model of Prostate Cancer. Cancer Research. 69(18). 7466–7472. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact